Visual Pathway Axonal Loss in Benign Multiple Sclerosis: A Longitudinal Study

被引:26
作者
Galetta, Kristin M. [1 ]
Graves, Jennifer [1 ]
Talman, Lauren S. [1 ]
Lile, Deacon J. [1 ]
Frohman, Elliot M. [4 ]
Calabresi, Peter A. [5 ]
Galetta, Steven L. [1 ,2 ]
Balcer, Laura J. [1 ,2 ,3 ]
机构
[1] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Epidemiol, Philadelphia, PA 19104 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
FIBER LAYER THICKNESS; TERM-FOLLOW-UP; OPTIC NEURITIS; BRAIN-DAMAGE; DISEASE; DISABILITY; CRITERIA; ATROPHY; VISION;
D O I
10.1097/WNO.0b013e318240204d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Benign multiple sclerosis (MS), traditionally defined as Expanded Disability Status Scale (EDSS) score <= 3 and >= 15-year disease duration, is thought to follow a milder clinical course. We determined the extent of visual pathway axonal loss by optical coherence tomography (OCT) retinal nerve fiber layer (RNFL) thickness in a benign MS cohort and examined the relation to vision and quality of life (QOL). Methods: In this longitudinal study of vision in MS at 3 academic centers, a subset of patients with EDSS, visual function, OCT, and QOL assessments was analyzed. Low and high-contrast letter acuity was performed to assess visual function. RNFL thickness was determined using time-domain OCT. QOL scales included the 25-Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Short Form-36 Health Survey. Results: Among 68 patients (135 eyes) studied longitudinally, 13 (26 eyes) had benign MS using criteria of EDSS score <= 3 and >= 15-year disease duration. Benign MS eyes had as much RNFL thinning (-3.6 mu m, P = 0.0008 vs base-line, paired t test) as typical MS eyes (-3.3 mu m, P < 0.0001). Both groups had significant low-contrast acuity loss. History of optic neuritis (ON) was more frequent in benign MS (69% vs 33% of eyes). History of ON distinguished benign vs typical MS (P = 0.002) and correlated with RNFL thickness at baseline (P = 0.002) and disease duration (P = 0.03) but not EDSS (P = 0.32, logistic regression). NEI-VFQ-25 scores were also worse for benign MS, accounting for age (75 +/- 21 vs 88 +/- 11, P = 0.005). Conclusion: Patients with benign MS have RNFL axonal loss that is as marked as that of typical MS and have reduced vision and QOL. While overall neurologic impairment is mild, visual dysfunction, not well captured by the EDSS, accounts for a substantial degree of disability in benign MS.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 45 条
[1]   Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis [J].
Amato, M. P. ;
Portaccio, E. ;
Stromillo, M. L. ;
Goretti, B. ;
Zipoli, V. ;
Siracusa, G. ;
Battaglini, M. ;
Giorgio, A. ;
Bartolozzi, M. L. ;
Guidi, L. ;
Sorbi, S. ;
Federico, A. ;
De Stefano, N. .
NEUROLOGY, 2008, 71 (09) :632-638
[2]   Benign multiple sclerosis - Cognitive, psychological and social aspects in a clinical cohort [J].
Amato, Maria Pia ;
Zipoli, Valentina ;
Goretti, Benedetta ;
Portaccio, Emilio ;
De Caro, Maria Fara ;
Ricchiuti, Laura ;
Siracusa, Gianfranco ;
Masini, Medena ;
Sorbi, Sandro ;
Trojano, Maria .
JOURNAL OF NEUROLOGY, 2006, 253 (08) :1054-1059
[3]   Natalizumab reduces visual loss in patients with relapsing multiple sclerosis [J].
Balcer, L. J. ;
Galetta, S. L. ;
Calabresi, P. A. ;
Confavreux, C. ;
Giovannoni, G. ;
Havrdova, E. ;
Hutchinson, M. ;
Kappos, L. ;
Lublin, F. D. ;
Miller, D. H. ;
O'Connor, P. W. ;
Phillips, J. T. ;
Polman, C. H. ;
Radue, E.-W. ;
Rudick, R. A. ;
Stuart, W. H. ;
Wajgt, A. ;
Weinstock-Guttman, B. ;
Wynn, D. R. ;
Lynn, F. ;
Panzara, M. A. .
NEUROLOGY, 2007, 68 (16) :1299-1304
[4]   "Benign'' and "normal appearing'': it's in the eye of the beholder [J].
Barkhof, Frederik .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (01) :4-4
[5]   Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial [J].
Beck, RW ;
Gal, RL ;
Bhatti, MT ;
Brodsky, MC ;
Buckley, EG ;
Chrousos, GA ;
Corbett, J ;
Eggenberger, E ;
Goodwin, JA ;
Katz, B ;
Kaufman, DI ;
Keltner, JL ;
Kupersmith, MJ ;
Miller, NR ;
Moke, PS ;
Nazarian, S ;
Orengo-Nania, S ;
Savino, PJ ;
Shults, WT ;
Smith, CH ;
Trobe, JD ;
Wall, M ;
Xing, DY .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (01) :77-83
[6]   A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients [J].
Benedetti, B. ;
Rocca, M. A. ;
Rovaris, M. ;
Caputo, D. ;
Zaffaroni, M. ;
Capra, R. ;
Bertolotto, A. ;
Martinelli, V. ;
Comi, G. ;
Filippi, M. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (01) :26-30
[7]   In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis [J].
Benedetti, B. ;
Rovaris, M. ;
Rocca, M. A. ;
Caputo, D. ;
Zaffaroni, M. ;
Capra, R. ;
Bertolotto, A. ;
Martinelli, V. ;
Comi, G. ;
Filippi, M. .
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (07) :789-794
[8]   Benign or not benign MS A role for routine neuropsychological assessment? [J].
Benedict, Ralph H. B. ;
Fazekas, Franz .
NEUROLOGY, 2009, 73 (07) :494-495
[9]   Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study [J].
Calabrese, M. ;
Filippi, M. ;
Rovaris, M. ;
Bernardi, V. ;
Atzori, M. ;
Mattisi, I. ;
Favaretto, A. ;
Grossi, P. ;
Barachino, L. ;
Rinaldi, L. ;
Romualdi, C. ;
Perini, P. ;
Gallo, P. .
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (01) :36-41
[10]   Multiple sclerosis [J].
Compston, Alastair ;
Coles, Alasdair .
LANCET, 2008, 372 (9648) :1502-1517